Quayside Medical Practice, a GP Surgery in Londonderry, played a crucial role in this launch project. "As a new user of iPLATO Patient Care Messaging we're looking forward to using text messaging to contact patients quickly as it is instant and convenient for both patient and the surgery," says Timothy Brown, I.T. Supervisor. "Using text messaging as a means to invite patients to different clinics as well as the automatic appointment reminders will be very beneficial in terms of staff time and resources especially during the flu jab season where we usually send out about 1,500 letters to patients. Our practice has 12,000 patients so there will considerable savings made over a period of time."
"High mobile penetration combined with significant healthcare challenges and serious health inequalities make Northern Ireland a very good environment for innovation in mHealth," says Tobias Alpsten, Managing Director at iPLATO. "We will work with NHS organisations across Northern Ireland to bring global best practice mHealth solutions to their patients. Following our strategy to develop world class mHealth tools in partnership with local health and care organisations we also hope to work with the Northern Ireland government on improving health through local mHealth Hubs and creating employment in this growth sector."
Related news articles:
- iPLATO's Profile
About iPLATO
iPLATO Healthcare is an innovation company dedicated to mobile health since 2006. iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.
Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.